Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-65,900
Closed -$3.8M 3653
2024
Q3
$3.8M Buy
65,900
+16,100
+32% +$869K 0.01% 1086
2024
Q2
$2.42M Buy
49,800
+15,500
+45% +$748K 0.01% 1360
2024
Q1
$1.67M Sell
34,300
-24,000
-41% -$1.17M ﹤0.01% 1597
2023
Q4
$2.9M Buy
58,300
+10,400
+22% +$509K ﹤0.01% 1379
2023
Q3
$2.57M Buy
+47,900
New +$2.55M ﹤0.01% 1339

Other funds holding SNY

GTS Securities's SNY Position: Q2 2025 in Review

GTS Securities sold out of Sanofi (SNY) in Q2 2025, closing a stake of 16,219 shares — an estimated $900K sold.

GTS Securities first reported a position in SNY in Q2 2023 and held it in 7 quarters. The position peaked at $5.99M in Q3 2024. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • GTS Securities reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • GTS Securities sold 16,219 Sanofi shares in Q2 2025, an estimated $900K.
  • GTS Securities first reported a position in Sanofi in Q2 2023 and held it in 7 quarters.
  • GTS Securities's Sanofi position peaked at $5.99M in Q3 2024.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on GTS Securities's 13F filing for Q2 2025, filed 8 Aug 2025.